Updated:
Save
After two years of hiatus due to the Covid pandemic, Spanish pharmacists and from all over the world will meet again in two congresses that will be held jointly in Seville from September 18 to 22, 2022: the 22 National Pharmaceutical Congress and the 80 World Congress of Pharmacy. The presidents of the General Council of Pharmacists, Jesús Aguilar; and from the International Pharmaceutical Federation (FIP), Dominique Jordan; They have been in charge of presenting both events today in Madrid.
Around 5,000 professionals (3,500 pharmacists from around the world and 1,500 from Spain) will participate in the Andalusian capital in the conference to review the role of the pharmaceutical profession during the pandemic and its contribution to more effective and efficient health systems.
«We arrived in Seville two years later, but we do it stronger, with more enthusiasm and, above all, with the experience and conviction of being a health profession that, both in Spain and throughout the world, has been essential to successfully overcome the greatest health crisis of the last century”, the President of the General Council pointed out during the presentation. Along the same lines, he has stated that «today’s world is very different from how it was two years ago. As humanity, we have assumed our collective vulnerability, and we have verified that only science, research and medicines have allowed us to overcome this emergency, which has demonstrated the need to strengthen health systems.
Aguilar stated that “Seville represents an extraordinary opportunity to continue showing the world the greatness of the pharmaceutical profession. The end of the pandemic will not be the end point. It must be a starting point to start a new path, take on new challenges and implement new services from which patients and health systems will benefit”.
In this sense, he recalled that the intervention of pharmacists in the supervision, performance, registration and notification of positive cases of Covid-19 through antigen tests “is allowing Primary Care to be more discharged.” In fact, during the first month and a half of this year alone, pharmacies supervised more than 600,000 tests and notified the health system of more than 82,000 positives, which represents 13.6% of the tests carried out.
For his part, IFJ President Dominique Jordan has drawn attention to the role of the profession over the past two years and its “strong dedication to serving our communities, which has shown that pharmacists and pharmacies are an integral part of health systems, a profession that is advancing at an unprecedented rate, expanding the scope of its activities to provide more services.” In his opinion, appointments like the one in Seville serve to “share the experiences carried out by pharmacists in the pandemic so that countries can learn from each other.” Jordan wanted to recognize the opportunity for this important event to be held in Spain, “a country that is an international example for its achievements in advancing Pharmacy both before and during Covid”.
With the motto ‘Pharmacy, united in the recovery of health care‘, the 80th World Congress of Pharmacy and Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP) will have participants from more than one hundred countries, will review the lessons learned around the world during the pandemic to prepare for future emergencies. All this through three large thematic blocks: Never miss a crisis, lessons to face the future; The science and evidence supporting the response to COVID-19; and How to deal with new and unique ethical challenges.
With the motto ‘We are pharmacists: Welfare, social and digital‘, the 22nd National Pharmaceutical Congress will feature 11 round tables or debates, 4 innovation sessions and 25 technical sessions, in which the most topical professional issues will be reviewed, such as the new models of continuity between care levels, Home Pharmaceutical Care , patient safety in the digital environment, professional opportunities, the work of the Pharmaceutical Profession, Social Innovation and Pharmacy Committee, COVID-19: current clinical and therapeutic aspects, the Portfolio of Professional Pharmaceutical Assistance Services in the SNS , Digitization, Public Health, etc.
See them
comments